Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Jun-24 9:45 PM View:  | Tempus Ai, Inc. (TEM) | 13-Jun-24 | Grant | 28,514 | -- | -- | 100% 0 to 28.51K | |
| 15-Dec-23 6:29 PM View: | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 16,407 | $229.00 | $3,757,200.00 | (100%) 16.41K to 0 | |
| 13-Nov-23 8:02 PM View: | Seattle Genetics Inc. (SGEN) | 10-Nov-23 | Private Sale (Planned) | 10,620 | $213.01 | $2,262,170.00 | (7%) 147.22K to 136.6K | |
| 17-Aug-23 9:14 PM View: | Seattle Genetics Inc. (SGEN) | 15-Aug-23 | Grant | 39,650 | -- | -- | 37% 107.57K to 147.22K | |
| 14-Nov-22 5:45 PM View: | Seattle Genetics Inc. (SGEN) | 09-Nov-22 | Grant | 107,389 | -- | -- | 100% 0 to 107.39K | |
| 30-Jun-22 4:52 PM View: | Evelo Biosciences, Inc. (EVLO) | 30-Jun-22 | Option Exercise | 4,927 | -- | -- | 6% 89.0K to 93.93K | |
| 10-Jun-22 9:22 PM View: | Senti Biosciences, Inc. (SNTI) | 08-Jun-22 | Grant | 112,519 | -- | -- | 1048% 10.73K to 123.25K | |
| 01-Jun-22 4:12 PM View: | Evelo Biosciences, Inc. (EVLO) | 31-May-22 | Option Exercise | 4,925 | -- | -- | 6% 84.08K to 89.0K | |
| 31-May-22 4:07 PM View: | Evelo Biosciences, Inc. (EVLO) | 27-May-22 | Private Purchase | 17,123 | $1.46 | $24,999.60 | 26% 66.96K to 84.08K | |
| 03-Jun-22 4:30 PM View: | Axcella Health Inc. (AXLA) | 19-May-22 | Grant | 47,059 | -- | -- | 29% 162.7K to 209.76K | |
| 02-May-22 4:03 PM View: | Evelo Biosciences, Inc. (EVLO) | 02-May-22 | Option Exercise | 4,926 | -- | -- | 8% 62.03K to 66.96K | |
| 22-Apr-22 6:07 PM View: | Rubius Therapeutics, Inc. (RUBY) | 21-Apr-22 | Private Purchase | 30,000 | $1.44 | $43,329.00 | < 1% 4.69M to 4.72M | |
| 01-Apr-22 4:05 PM View: | Evelo Biosciences, Inc. (EVLO) | 31-Mar-22 | Option Exercise | 4,926 | -- | -- | 9% 57.1K to 62.03K | |
| 21-Mar-22 4:30 PM View: | Axcella Health Inc. (AXLA) | 18-Mar-22 | Option Exercise | 1,535 | -- | -- | < 1% 161.16K to 162.7K | |
| 18-Mar-22 8:30 AM View: | Axcella Health Inc. (AXLA) | 16-Mar-22 | Market Purchase | 26,178 | $1.91 | $50,000.00 | 19% 134.98K to 161.16K | 3% |
| 01-Mar-22 4:07 PM View: | Evelo Biosciences, Inc. (EVLO) | 28-Feb-22 | Option Exercise | 4,926 | -- | -- | 9% 52.18K to 57.1K | |
| 23-Feb-22 4:19 PM View: | Axcella Health Inc. (AXLA) | 18-Feb-22 | Option Exercise | 1,534 | -- | -- | 1% 133.45K to 134.98K | |
| 31-Jan-22 5:06 PM View: | Evelo Biosciences, Inc. (EVLO) | 31-Jan-22 | Option Exercise | 4,925 | -- | -- | 10% 47.25K to 52.18K | |
| 20-Jan-22 4:30 PM View: | Axcella Health Inc. (AXLA) | 18-Jan-22 | Option Exercise | 1,535 | -- | -- | 1% 131.91K to 133.45K | |
| 03-Jan-22 4:23 PM View: | Evelo Biosciences, Inc. (EVLO) | 31-Dec-21 | Option Exercise | 4,926 | -- | -- | 12% 42.33K to 47.25K | |
| 20-Dec-21 4:15 PM View: | Axcella Health Inc. (AXLA) | 17-Dec-21 | Option Exercise | 1,535 | -- | -- | 1% 130.38K to 131.91K | |
| 01-Dec-21 4:39 PM View: | Evelo Biosciences, Inc. (EVLO) | 30-Nov-21 | Option Exercise | 4,926 | -- | -- | 13% 37.4K to 42.33K | |
| 22-Nov-21 6:04 PM View: | Axcella Health Inc. (AXLA) | 18-Nov-21 | Option Exercise | 1,534 | -- | -- | 1% 128.85K to 130.38K | |
| 01-Nov-21 5:22 PM View: | Evelo Biosciences, Inc. (EVLO) | 01-Nov-21 | Option Exercise | 4,925 | -- | -- | 15% 32.48K to 37.4K | |
| 19-Oct-21 4:31 PM View: | Axcella Health Inc. (AXLA) | 18-Oct-21 | Option Exercise | 1,535 | -- | -- | 1% 127.31K to 128.85K | |
| 01-Oct-21 4:42 PM View: | Evelo Biosciences, Inc. (EVLO) | 01-Oct-21 | Option Exercise | 4,927 | -- | -- | 18% 27.55K to 32.48K | |
| 20-Sep-21 4:31 PM View: | Axcella Health Inc. (AXLA) | 17-Sep-21 | Option Exercise | 1,535 | -- | -- | 1% 125.78K to 127.31K | |
| 03-Sep-21 4:55 PM View: | Evelo Biosciences, Inc. (EVLO) | 03-Sep-21 | Option Exercise | 9,850 | -- | -- | 56% 17.7K to 27.55K | |
| 20-Jul-21 4:31 PM View: | Axcella Health Inc. (AXLA) | 16-Jul-21 | Option Exercise | 1,535 | -- | -- | 1% 122.71K to 124.24K | |
| 21-Jun-21 5:42 PM View: | Axcella Health Inc. (AXLA) | 18-Jun-21 | Option Exercise | 1,535 | -- | -- | 1% 121.17K to 122.71K | |
| 20-May-21 4:31 PM View: | Axcella Health Inc. (AXLA) | 18-May-21 | Option Exercise | 1,534 | -- | -- | 1% 119.64K to 121.17K | |
| 20-Apr-21 4:58 PM View: | Axcella Health Inc. (AXLA) | 18-Apr-21 | Option Exercise | 1,535 | -- | -- | 1% 118.1K to 119.64K | |
| 16-Feb-21 9:51 PM View: | Rubius Therapeutics, Inc. (RUBY) | 11-Feb-21 | Market Sale (Planned) | 26,704 | $14.93 | $398,560.00 | (< 1%) 4.72M to 4.69M | 13% |
| 10-Feb-21 9:12 PM View: | Rubius Therapeutics, Inc. (RUBY) | 10-Feb-21 | Market Sale (Planned) | 7,404 | $14.79 | $109,525.00 | (< 1%) 4.72M to 4.72M | 3% |
| 10-Feb-21 9:12 PM View: | Rubius Therapeutics, Inc. (RUBY) | 09-Feb-21 | Market Sale (Planned) | 2,100 | $14.83 | $31,145.90 | (< 1%) 4.73M to 4.72M | 3% |
| 10-Feb-21 9:12 PM View: | Rubius Therapeutics, Inc. (RUBY) | 08-Feb-21 | Market Sale (Planned) | 89,233 | $14.88 | $1,328,120.00 | (2%) 4.82M to 4.73M | 3% |
| 14-Dec-20 5:15 PM View: | Evelo Biosciences, Inc. (EVLO) | 11-Dec-20 | Market Purchase | 7,700 | $6.66 | $51,260.80 | 77% 10.0K to 17.7K | 61% |
| 01-Sep-20 4:13 PM View: | Evelo Biosciences, Inc. (EVLO) | 31-Aug-20 | Market Purchase | 5,752 | $4.49 | $25,803.90 | 135% 4.25K to 10.0K | 139% |
| 01-Sep-20 4:13 PM View: | Evelo Biosciences, Inc. (EVLO) | 28-Aug-20 | Market Purchase | 4,248 | $4.39 | $18,631.20 | 100% 0 to 4.25K | 145% |
| 20-May-20 4:07 PM View: | Axcella Health Inc. (AXLA) | 18-May-20 | Purchase | 50,000 | $4.75 | $237,500.00 | 73% 68.1K to 118.1K | |
| 19-Mar-20 6:34 PM View: | Rubius Therapeutics, Inc. (RUBY) | 17-Mar-20 | Market Purchase | 5,000 | $3.76 | $18,800.00 | < 1% 4.81M to 4.82M | 282% |
| 17-Mar-20 5:59 PM View: | Rubius Therapeutics, Inc. (RUBY) | 13-Mar-20 | Market Purchase | 10,000 | $3.91 | $39,100.00 | < 1% 4.8M to 4.81M | 267% |
| 02-Mar-20 7:04 PM View: | Axcella Health Inc. (AXLA) | 28-Feb-20 | Market Purchase | 2,005 | $3.75 | $7,518.75 | 3% 66.1K to 68.1K | |
| 02-Mar-20 7:04 PM View: | Axcella Health Inc. (AXLA) | 27-Feb-20 | Market Purchase | 12,800 | $3.65 | $46,720.00 | 24% 53.3K to 66.1K | |
| 02-Dec-19 7:31 PM View: | Axcella Health Inc. (AXLA) | 27-Nov-19 | Market Purchase | 1,005 | $3.91 | $3,929.55 | 2% 52.29K to 53.3K | |
| 03-Dec-19 11:20 AM View: | Axcella Health Inc. (AXLA) | 27-Nov-19 | Market Purchase Duplicate | 1,005 | $3.91 | $3,929.55 | 2% 52.29K to 53.3K | |
| 02-Dec-19 7:31 PM View: | Axcella Health Inc. (AXLA) | 26-Nov-19 | Market Purchase | 14,000 | $3.55 | $49,700.00 | 37% 38.29K to 52.29K | |
| 03-Dec-19 11:20 AM View: | Axcella Health Inc. (AXLA) | 26-Nov-19 | Market Purchase Duplicate | 14,000 | $3.55 | $49,700.00 | 37% 38.29K to 52.29K | |
| 05-Aug-19 4:55 PM View: | Axcella Health Inc. (AXLA) | 02-Aug-19 | Market Purchase | 2,849 | $7.04 | $20,057.00 | 8% 35.44K to 38.29K | |
| 05-Aug-19 4:55 PM View: | Axcella Health Inc. (AXLA) | 01-Aug-19 | Market Purchase | 4,092 | $6.98 | $28,562.20 | 13% 31.35K to 35.44K |